Tandem Diabetes Care, Inc. recalls Brand Name
- Published
- 7 Oct 2026
- Units affected
- 177
- Agency
- FDA
- Country
- United States
The hazard
A beta (early-release) version of the iOS application, version 2.13 (TestFlight) had a software issue preventing successful pairing of the t:slim application with Abbott FreeStyle Libre 3 Plus (FSL3P) continuous glucose monitoring (CGM) sensors, resulting in the insulin pump being unable to establish a near-field communication (NFC) connection with the CGM and requiring FSL3P users to use their t:slim insulin pumps in manual mode. FSL3P users are unable to access their CGM's glucose values from within the t:slim app and cannot use their pumps in automated control (closed-loop) mode, which could lead to users experiencing hypoglycemia or hyperglycemia.
Classification: Class II — this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What to do
Contact your doctor, clinic or the device maker to find out if your device is affected and what to do next. Do not stop using a life-supporting device without medical advice.
- Check the model and lot or serial number on the device label.
- Speak to your doctor or the clinic that supplied the device before stopping use.
Product details
Brand Name: Tandem t:slim mobile application Product Name: t:slim Mobile Application, iOS Model/Catalog Number: iOS software version 2.13 Software Version: iOS software version 2.13 UDI-DI: 00389152470740 Component: No
- Brand / company
- Tandem Diabetes Care, Inc.
- Codes / lots
- Lot Code: UDI-DI: 00389152470641 Software Version: 2.13 (iOS only)
- Distribution
- US Nationwide distribution.
- Recall status
- Ongoing
Source: U.S. Food and Drug Administration, published 7 Oct 2026. CheckMyRecalls reproduces the official notice in summary; always confirm the details with the original notice.